Original Research

Economic Impact of Increased Utilization of Multivariate Assay Testing to Guide the Treatment of Ovarian Cancer: Implications for Payers

Burton S. Brodsky, MD; Gary M. Owens, MD; Dennis J. Scotti, PhD, MBA; Keith A. Needham, BS; Christina L. Cool, MPH

Stakeholder Perspective

Economic Impact of Using Tests to Guide the Treatment of Patients with Ovarian Cancer

F. Randy Vogenberg, PhD, RPh

Clinical, Original Research

Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide

Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Dominic Pilon, MA; Yongling Xiao, PhD; Patrick Lefebvre, MA

Stakeholder Perspective

A First Step Toward Improving the Complex Approach to Metastatic Prostate Cancer Management

Gary M. Owens, MD

Clinical, Original Research

The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data

Annlouise R. Assaf, PhD; Andrew G. Bushmakin, MS; Nina Joyce, PhD; Michael J. Louie, MD, MPH, MSc; Michael Flores, MPH; Margaret Moffatt, MPH

Stakeholder Perspective

Hormone Therapy Remains Effective for Treating Menopausal Symptoms, May Save Overall Costs

JoAnn V. Pinkerton, MD, FACOG, NCMP

Business, Original Research

Costs and Effectiveness of Mindfulness-Based Art Therapy versus Standard Breast Cancer Support Group for Women with Cancer

Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD; Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD

Stakeholder Perspective

Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care

Linda Bily, MA, CSA, OPN-CG

Business, Original Research

Budget Impact of a Comprehensive Nutrition-Focused Quality Improvement Program for Malnourished Hospitalized Patients

Suela Sulo, PhD; Josh Feldstein, BA; Jamie Partridge, PhD, MBA; Bjoern Schwander, MS, RN; Krishnan Sriram, MD; Wm. Thomas Summerfelt, PhD

Stakeholder Perspective

The Crucial Role of Nutrition Support Services for Hospitalized Patients

Jack E. Fincham, PhD, RPh

Clinical, Original Research

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes

Kelvin Lingjet Tran, DO; Young In Park, DO; Shalin Pandya, DO; Navin John Muliyil, DO; Brandon David Jensen, DO; Kovin Huynh, DO; Quang T. Nguyen, DO, FACP, FACE, FTOS

Stakeholder Perspective

The GLP-1 Receptor Agonists Are Cost-Effective for the Treatment of Type 2 Diabetes

Raymond Plodkowski, MD

Business, Original Research

The Clinical and Economic Burden of Hyperkalemia on Medicare and Commercial Payers

Kathryn Fitch, RN, MEd; J. Michael Woolley, PhD; Tyler Engel, ASA, MAAA; Helen Blumen, MD, MBA

Stakeholder Perspective

Hyperkalemia in Chronic Diseases: A Serious Medical Condition in Need of Clinical Guidelines and New Treatment Options

Quang T. Nguyen, DO, FACP, FACE, FTOS

Clinical, Original Research

Comparing Medication Adherence and Persistence Among Patients with Type 2 Diabetes Using Sodium-Glucose Cotransporter 2 Inhibitors or Sulfonylureas

Kelly F. Bell, PharmD, MSPhr, MS; Katherine Cappell, PhD; Michael Liang, MS; Amanda M. Kong, MPH

Stakeholder Perspective

Real-World Studies in Diabetes Needed to Improve Medication Adherence and Persistence

Brian Caveney, MD, JD, MPH

Clinical, Original Research

Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea

Todd Williamson, MsC; Rajesh Kamalakar, MS; Augustina Ogbonnaya, MPH; Erin A. Zagadailov, PharmD, MS; Michael Eaddy, PharmD, PhD; Charlie Kreilick, MBA

Stakeholder Perspective

The Challenge of Rosacea Treatment

Atheer A. Kaddis, PharmD

Clinical, Original Research

Comparing Healthcare Utilization and Costs Among Medicaid-Insured Patients with Chronic Noncancer Pain with and without Opioid-Induced Constipation: A Retrospective Analysis

Tope Olufade, PhD, MPH; Amanda M. Kong, MPH; Nicole Princic, MS; Paul Juneau, MS; Rucha Kulkarni, MPH; Kui Zhang, MD; Catherine Datto, MD, MS

Stakeholder Perspective

The Opioid Epidemic: Healthcare Utilization and Cost Considerations

Jack E. Fincham, PhD, RPh

Page 9 of 11
Results 81 - 90 of 107

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Special Print Editions

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.